Products

Online Inquiry

* First Name

* Last Name

Phone

* Business Email

Company/Institution

Job Title

* Services or Products of Interest

When do you expect your project to start?

Project Description

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

ATWLPPR peptide TFA

Cat. No: CDIA-0660

Size: 10 mg

Price: Inquiry

Product Details
Formula	C42H62F3N11O11
Molecular Weight	954.00
Appearance	Solid
Purity	99.34%
Smiles String	O=C(N[[email protected]@H]([[email protected]](O)C)C(N[[email protected]@H](CC1=CNC2=CC=CC=C12)C(N[[email protected]@H](CC(C)C)C(N3[[email protected]@H](CCC3)C(N4[[email protected]@H](CCC4)C(N[[email protected]@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)[[email protected]](C)N.OC(C(F)(F)F)=O

Storage & Handling
Shipping	Room temperature.
Storage	Sealed storage, away from moisture and light *In solvent : -80 °C, 6 months; -20 °C, 1 month (sealed storage, away from moisture and light)
Storage Powder	-80 °C/2 years, -20 °C/1 year

Description

ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis. ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes.

! For research use only. Not intended for any clinical use.